ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,555.74
-0.16%
US Tech 100
19,107.20
-1.02%
Dow Jones
40,358.09
-0.14%
Brent Oil
80.625
-0.19%
Bitcoin
65,858.71
-0.10%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSX

  6. Eupraxia Pharmaceuticals Inc (EPRX) Quote

Eupraxia Pharmaceuticals Inc

Eupraxia Pharmaceuticals Inc (EPRX)

Eupraxia Pharmaceuticals Inc
3.46
0.06
(1.76%)
Closed July 23 4:12PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
3.46
Bid
3.46
Ask
3.63
Volume
4,090
3.46 Day's Range 3.60
3.25 52 Week Range 8.46
Market Cap
94.396M
Previous Close
3.40
Open
3.56
Last Trade
100
@
3.46
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
16,810
Shares Outstanding
27,282,000
Dividend Yield
-
PE Ratio
-3.34
Earnings Per Share (EPS)
-1.03
Revenue
-
Net Profit
-28.22M

About Eupraxia Pharmaceuticals Inc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.eupraxiapharma.com
Headquarters
Victoria, British Columbia, Can
Founded
1970
Eupraxia Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the Toronto Stock Exchange with ticker EPRX. The last closing price for Eupraxia Pharmaceuticals was $3.40. Over the last year, Eupraxia Pharmaceuticals shares have traded in a share price range of $ 3.25 to $ 8.46.

Eupraxia Pharmaceuticals currently has 27,282,000 shares outstanding. The market capitalization of Eupraxia Pharmaceuticals is $92.76 million. Eupraxia Pharmaceuticals has a price to earnings ratio (PE ratio) of -3.34.

EPRX Latest News

More News

Eupraxia Pharmaceuticals to Present at Controlled Release Society 2024 Annual Meeting and Expo

Eupraxia Pharmaceuticals to Present at Controlled Release Society 2024 Annual Meeting and Expo Canada NewsWire VICTORIA, BC, July 8, 2024 VICTORIA, BC, July 8, 2024 /CNW/ - Eupraxia...

July 08 2024
PR Newswire (Canada)

Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Exploring the Rapid Rise of Osteoarthritis" on July 9, 2024

Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Exploring the Rapid Rise of Osteoarthritis" on July 9, 2024 Canada NewsWire VICTORIA, BC, July 3...

July 03 2024
PR Newswire (Canada)

Eupraxia Pharmaceuticals Announces Voting Results from Annual General and Special Meeting of Shareholders

Eupraxia Pharmaceuticals Announces Voting Results from Annual General and Special Meeting of Shareholders PR Newswire VICTORIA, BC, June 6, 2024 VICTORIA, BC, June 6, 2024 /PRNewswire/ - Eupraxia...

June 06 2024
PR Newswire (US)

Eupraxia Pharmaceuticals to Present Data from the Phase 2 SPRINGBOARD Study in Osteoarthritis of the Knee at EULAR European Congress of Rheumatology 2024

Eupraxia Pharmaceuticals to Present Data from the Phase 2 SPRINGBOARD Study in Osteoarthritis of the Knee at EULAR European Congress of Rheumatology 2024 PR Newswire VICTORIA, BC, June 5, 2024...

June 05 2024
PR Newswire (US)

Eupraxia Pharmaceuticals Announces Expansion of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

Eupraxia Pharmaceuticals Announces Expansion of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis PR Newswire VICTORIA, BC, May 23, 2024 Eight of nine patients...

May 23 2024
PR Newswire (US)

Eupraxia Pharmaceuticals to Host Virtual KOL Event on EP-104GI Clinical Development Program for Eosinophilic Esophagitis ("EoE") on May 29, 2024

Eupraxia Pharmaceuticals to Host Virtual KOL Event on EP-104GI Clinical Development Program for Eosinophilic Esophagitis ("EoE") on May 29, 2024 PR Newswire VICTORIA, BC, May 22, 2024...

May 22 2024
PR Newswire (US)

Eupraxia Pharmaceuticals Announces New Positive Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

Eupraxia Pharmaceuticals Announces New Positive Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis PR Newswire VICTORIA, BC, May 21, 2024 Trial's first...

May 21 2024
PR Newswire (US)

Eupraxia Pharmaceuticals to Present Initial Results from Ongoing Phase 1b Study of EP-104GI for the Treatment of Eosinophilic Esophagitis at Upcoming Digestive Disease Week Annual Meeting 2024

Eupraxia Pharmaceuticals to Present Initial Results from Ongoing Phase 1b Study of EP-104GI for the Treatment of Eosinophilic Esophagitis at Upcoming Digestive Disease Week Annual Meeting...

May 14 2024
PR Newswire (Canada)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.24-6.486486486493.73.73.3280293.46106018CS
4-0.24-6.486486486493.73.743.25122493.51396518CS
12-0.24-6.486486486493.74.13.25168103.76858823CS
26-1.81-34.34535104365.277.643.25425204.42397001CS
52-4.16-54.5931758537.628.463.25330055.24415385CS
156-0.44-11.28205128213.99.10.8269664.17128109CS
260-4.29-55.35483870977.759.10.8257564.25818758CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DCAPUnity Wealth Partners Dynamic Capital Appreciation & Options ETF
 20.10
(839.25%)
128.82k
RGCRegencell Bioscience Holdings Ltd
$ 15.15
(349.55%)
1.34M
ATPCAgape ATP Corporation
$ 0.2262
(58.18%)
107.31M
SLRXSalarius Pharmaceuticals Inc
$ 2.34
(51.95%)
60.04M
GSUNGolden Sun Health Technology Group Ltd
$ 7.46
(45.42%)
589.98k
FLYEFly E Group Inc
$ 1.1601
(-81.82%)
25.44M
RNAZTransCode Therapeutics Inc
$ 0.3035
(-61.70%)
9.78M
JAGXJaguar Health Inc
$ 1.755
(-58.90%)
15.47M
MIRAMIRA Pharmaceuticals Inc
$ 2.55
(-49.10%)
25.64M
IVPInspire Veterinary Partners Inc
$ 5.19
(-43.83%)
1.67M
SLNASelina Hospitality PLC
$ 0.026
(-29.73%)
220.32M
SPWRSunPower Corporation
$ 0.9514
(32.91%)
186.76M
NVDANVIDIA Corporation
$ 122.59
(-0.77%)
173.9M
ADILAdial Pharmaceuticals Inc
$ 1.3422
(26.62%)
160.04M
HOLOMicroCloud Hologram Inc
$ 0.588
(26.07%)
135.56M

Discussion

View Full Feed
2H2 2H2 2 minutes ago
Foxcon promised 13,000 new jobs in Wisconsin, T bag wet his pants over Taiwans false promise. Wisconsin governor at the time Scott Walker was wearing diapers he was so excited. They all got paid off and the project failed. Now Microsoft was to put an AI facility there. What?? Youall believe T Bag an
just Scottie just Scottie 2 minutes ago
Management certainly need ms a home run business plan and Pr
Big celebrity again or announce products to be sold in a Walmart or large American grocery chain
KITL
FireMechanic FireMechanic 2 minutes ago
Not tomorrow,next week,next month or even next year the market will implode. Trillions of securities sold not yet purchased they can only pass the hot potato back and forth for so long. 75% of the revenue taken by our government goes to pay the interest on debt. I believe this is why the big push is
HNRC
bbotcs bbotcs 2 minutes ago
lj: NOG
I stopped watching it. Will start paying attention to it.
Have a good evening, what's left of it!
I'm hitting the hay early.
Legster1969 Legster1969 3 minutes ago
Please. This happens a million times with this stock. It will go back up in due time, as it always does.
NSAV
Dr Blunt Dr Blunt 3 minutes ago
0.000001 0.00 (0.00%) Volume: - 0
$MSTO
Masterbeat Corporation
MSTO
Vexari Vexari 3 minutes ago
22 architypes describing the law of one

static-3.bitchute.com/live/cover_images/D1sWU5web333/gucmcYAlnJxb_320x180.jpg old.bitchute.com/video/gucmcYAlnJxb/ ~~~ Being able to differentiate ~~~
(4:20:51)

Is key

old.bitchute.com/channel/D1sWU5web3
Legster1969 Legster1969 3 minutes ago
That's not all I need to know. I need to know if 10k equals 10k or 3 million shares.
NSAV
arachnodude arachnodude 3 minutes ago
From an anonymous message board poster crying because the share price hasn't done what they thought it would do by now. But the CEO has "credibility issues." I can't. I can't anymore...🤣🤣🤣
KBLB
fuagf fuagf 4 minutes ago
They are brilliant. Thanks for bringing them back. This, in reply to your there and here, is slightly OT

https://twitter.com/KvotheTheArcane/status/1815914473129140534
Sadly, OTW could say.
bbotcs bbotcs 4 minutes ago
lj: SMCI
I need to pay attention to the moving averages.
OT: Deer ate all but one of my tomato plants. I am not amused.
SMCI
SoxFan SoxFan 5 minutes ago
Thank you for at least providing an article that reaffirms what I was stating that she was not the Boarder Czar. That was in the NPR article.
PennyPusher786 PennyPusher786 6 minutes ago
Personally, i think that was as high as it was gonna go for a lonnnnnnng while....lol....
AZTR
oldstocks oldstocks 7 minutes ago
The Non Disclosure Agreements on the unknown mergers has tide up OneMind Technologies SL and Affluence/Durham Black.
While the unknown companies are growing and posting new things and news, but since we are not suppose to know who they are they don't have to follow the agreements because we
AFFU DLOC SMCE
PennyPusher786 PennyPusher786 7 minutes ago
Nothing new.
BNED
Bikesandbeer Bikesandbeer 8 minutes ago
No filings = no go. Remember the fake countdown last fall. lol
FBEC
wadegarret wadegarret 8 minutes ago
R59- GERN

I can't win lately ! I didn't see the news till now, but the Chief Commercial Officer is leaving end of Aug, and the stock tanked 10% after hours. https://finance.yahoo.com/news/geron-corporation-announces-chief-commercial-201500531.html

Re, how do y
GERN
arachnodude arachnodude 8 minutes ago
Just dumbasses who cry every time they bring up contentious points to rile the masses and then play victim when someone shoots down their ridiculous notions.
KBLB
ThirdEyeAnalyst ThirdEyeAnalyst 9 minutes ago
is it time? or is the correct time later?

Are all bears genuine? Are all bulls pure?

Answer those questions

And let's take a tour

Past names, new names, all looking for fame

Pump groups, dump groups

Yawn.
AABB
noradio noradio 10 minutes ago
ASCM
HIRU
gimmegimmeminemine gimmegimmeminemine 10 minutes ago
Everybody else who has ATTEMPTED to bring Spider Silk to market is believable but the one who is actually doing it has "credibility issues?"
Now you are putting words in my mouth. I never mentioned anyone else attempting to create spidersilk had credibility issues. Just the CEO of KBLB.
KBLB
Monroe1 Monroe1 11 minutes ago
https://www.bbc.com/news/world-us-canada-56516332

https://www.npr.org/2024/07/22/nx-s1-5048025/kamala-harris-immigration-policy-border-central-america

https://www.latimes.com/politics/story/2024-02-05/kamala-harris-was-tapped-to-fix-an-immigration-crisis-but-the-target-
SoxFan SoxFan 11 minutes ago
You're out of your element in talking about VISAS with me. If in your wet dream we are only taking uneducated people with VISAS you have no clue what the VISA program is all about. While it does take longer it's because there is more Vetting and that's a good thing. We are not taking what Trump love
TTsr TTsr 11 minutes ago
From the link:

“The invention generally relates to cell culture chambers, and specifically to systems and methods for pumping fluids to and from cell culture chambers.

An automated cell culture system with one or more pumps configured to operate on a duty cycle prevent
NWBO
facts_matter14 facts_matter14 12 minutes ago
Can we hold you accountable for this comment:



https://investorshub.advfn.com/uimage/uploads/2024/7/23/bsrigIMG_4799.jpeg



POSVOS was marketed PERFECTLY?

https://investorshub.advfn.com/uimage/uploads/2024/7/17/lintkIMG_4727.g
SRMX

Your Recent History

TSX
EPRX
Eupraxia Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved